Quantinno Capital Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Buy
527,966
+186,623
+55% +$4.19M 0.01% 908
2026
Q1
$7.7M Buy
341,343
+46,428
+16% +$1.07M 0.01% 968
2025
Q4
$7.02M Buy
294,915
+57,923
+24% +$1.44M 0.01% 917
2025
Q3
$6.24M Buy
236,992
+54,770
+30% +$1.41M 0.02% 841
2025
Q2
$5.21M Buy
182,222
+5,078
+3% +$136K 0.02% 788
2025
Q1
$4.41M Buy
177,144
+49,418
+39% +$1.18M 0.03% 702
2024
Q4
$2.89M Buy
127,726
+17,648
+16% +$383K 0.03% 706
2024
Q3
$2.34M Buy
110,078
+48,554
+79% +$956K 0.03% 666
2024
Q2
$1.17M Sell
61,524
-20,947
-25% -$427K 0.02% 762
2024
Q1
$1.59M Buy
82,471
+37,145
+82% +$736K 0.03% 592
2023
Q4
$944K Buy
45,326
+5,185
+13% +$99.6K 0.03% 639
2023
Q3
$865K Buy
40,141
+15,604
+64% +$379K 0.04% 554
2023
Q2
$587K Sell
24,537
-271
-1% -$6.21K 0.03% 587
2023
Q1
$527K Buy
24,808
+2,520
+11% +$48.2K 0.03% 565
2022
Q4
$364K Buy
+22,288
New +$330K 0.03% 624

Other funds holding FMS

Quantinno Capital Management's FMS Position: Q2 2026 in Review

Quantinno Capital Management increased its Fresenius Medical Care (FMS) stake by 55% in Q2 2026, buying an estimated $4.19M and bringing the position to 527,966 shares worth $11.9M. The position accounts for 0.01% of the portfolio, ranked #908.

Quantinno Capital Management first reported a position in FMS in Q4 2022 and has held it in 15 quarters since. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Quantinno Capital Management held 527,966 shares of Fresenius Medical Care worth $11.9M as of Q2 2026.
  • Quantinno Capital Management bought 186,623 Fresenius Medical Care shares in Q2 2026, an estimated $4.19M.
  • Fresenius Medical Care made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #908 holding.
  • Quantinno Capital Management first reported a position in Fresenius Medical Care in Q4 2022 and has held it in 15 quarters since.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.